Glionova AB

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

Istari Oncology

This clinical-stage biotechnology company develops immuno-oncology platforms and immunotherapies to treat patients with glioblastoma and other solid tumours.

Alpheus Medical

This company develops a non-invasive sonodynamic therapy platform using low-intensity ultrasound and tumor-localising drugs to treat patients with glioblastoma and other brain cancers.

Trogenix

Trogenix develops precision gene therapies and synthetic super-enhancers for patients with aggressive solid tumours, including glioblastoma and colorectal cancer liver metastases.

KiraGen Bio

This biotechnology company develops gene-edited cell therapies to treat solid tumours for patients with glioblastoma and other cancers.

Hemispherian

This pharmaceutical company develops small-molecule drugs targeting the TET2 enzyme to treat aggressive cancers such as glioblastoma for patients with unmet medical needs.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

QV Bioelectronics

The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.